ALNYLAM PHARMACEUTICALS INC COM USD0.01ALNYLAM PHARMACEUTICALS INC COM USD0.01ALNYLAM PHARMACEUTICALS INC COM USD0.01

ALNYLAM PHARMACEUTICALS INC COM USD0.01

No trades
See on Supercharts

0HD2 fundamentals

ALNYLAM PHARMACEUTICALS INC COM USD0.01 revenue breakdown overview

ALNYLAM PHARMACEUTICALS INC COM USD0.01 revenue for the last year amounted to 1.83 B USD, the most of which — 1.83 B USD — came from its highest performing source at the moment, Ribonucleic Acid Interference Therapeutics, the year earlier bringing 1.04 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought ALNYLAM PHARMACEUTICALS INC COM USD0.01 1.28 B USD, and the year before that — 615.72 M USD.

By source
By country